Detailed epitope mapping of SARS-CoV-2 nucleoprotein reveals specific immunoresponse in cats and dogs housed with COVID-19 patients.


Journal

Research in veterinary science
ISSN: 1532-2661
Titre abrégé: Res Vet Sci
Pays: England
ID NLM: 0401300

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 27 07 2021
revised: 01 12 2021
accepted: 28 12 2021
pubmed: 9 1 2022
medline: 23 2 2022
entrez: 8 1 2022
Statut: ppublish

Résumé

Since the initial emergence in December 2019, the novel Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been reported in over 200 countries, representing an unprecedented challenge related to disease control worldwide. In this context, cases of human to animal transmission have been reported, raising concern about the potential role of companion animals in the pandemic and stressing the need for reliable animal testing. In the study, a detailed epitope mapping of SARS-CoV-2 nucleoprotein, using both human and pet sera, allowed the identification of the most antigenic region in the C-terminus domain of the protein, which was used to develop an experimental double antigen-based ELISA. A panel of pre-pandemic sera and sera of animals immunized against (or naturally infected with) related coronaviruses was used to assess assay specificity at 99.5%. Positive sera belonging to animals housed with COVID-19 patients were confirmed with the experimental double-antigen ELISA using Plaque Reduction Neutralization test (PRNT) test as gold standard. The availability of a serological assay that targets a highly specific viral antigen represents a valuable tool for multispecies monitoring of Coronavirus Disease 2019 (COVID-19) infection in susceptible animals.

Identifiants

pubmed: 34998208
pii: S0034-5288(21)00364-7
doi: 10.1016/j.rvsc.2021.12.020
pmc: PMC8723757
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Coronavirus Nucleocapsid Proteins 0
Phosphoproteins 0
nucleocapsid phosphoprotein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-87

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Références

Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4
pubmed: 33031947
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Virology. 1994 Jul;202(1):146-53
pubmed: 7516595
Adv Exp Med Biol. 1993;342:449-53
pubmed: 8209767
Emerg Infect Dis. 2021 Jul;27(7):1919-1922
pubmed: 33974535
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Virus Res. 2006 Dec;122(1-2):119-26
pubmed: 16920216
EBioMedicine. 2020 Dec;62:103101
pubmed: 33160207
J Clin Virol. 2021 Nov;144:104986
pubmed: 34563862
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Chem. 2005 Aug;51(8):1382-96
pubmed: 15976093
Clin Microbiol Infect. 2020 Nov;26(11):1557.e1-1557.e7
pubmed: 32745595
Vet Microbiol. 2000 Jul 3;75(1):11-6
pubmed: 10865148
PLoS One. 2020 Nov 2;15(11):e0237828
pubmed: 33137138
Microbiol Spectr. 2021 Dec 22;9(3):e0088621
pubmed: 34787495
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Pathogens. 2020 Jun 30;9(7):
pubmed: 32629960
Front Vet Sci. 2021 Feb 10;8:619207
pubmed: 33644148
J Mol Biol. 1982 May 5;157(1):105-32
pubmed: 7108955
J Med Virol. 2021 May;93(5):3092-3104
pubmed: 33565617
Virus Res. 2014 Dec 19;194:175-83
pubmed: 24670324
ACS Cent Sci. 2020 Dec 23;6(12):2238-2249
pubmed: 33372199
J Clin Microbiol. 2004 Nov;42(11):5309-14
pubmed: 15528730
Emerg Infect Dis. 2021;27(7):1981-1984
pubmed: 33979566
Front Vet Sci. 2020 Oct 27;7:591216
pubmed: 33195627
J Virol. 2021 Jan 13;95(3):
pubmed: 33144321
Genomics Proteomics Bioinformatics. 2003 Aug;1(3):198-206
pubmed: 15629032
Transbound Emerg Dis. 2022 Sep;69(5):3073-3076
pubmed: 34469620
Curr Protoc Bioinformatics. 2002 Aug;Chapter 2:Unit 2.3
pubmed: 18792934
Sci Immunol. 2020 Dec 22;5(54):
pubmed: 33443036
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32229605
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
PLoS One. 2020 Dec 31;15(12):e0244126
pubmed: 33382764
Biochem Biophys Res Commun. 2020 Jun 30;527(3):618-623
pubmed: 32416961

Auteurs

Barbara Colitti (B)

Department of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Torino, Italy. Electronic address: barbara.colitti@unito.it.

Francesco Bonfante (F)

Department of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Universita' 10, 35020 Legnaro, PD, Italy.

Santina Grazioli (S)

National Reference Centre for Vesicular Diseases, Dpt. Biotechnology, OIE/FAO reference laboratories for FMD and for SVD, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Via Bianchi 9, 25124, Brescia, Italy.

Laura Anfossi (L)

Department of Chemistry, University of Turin, Via Giuria, 5, I-10125 Turin, Italy.

Chiara Nogarol (C)

In3Diagnostic s.r.l., Largo Paolo Braccini 2, 10095 Grugliasco, Torino, Italy.

Daniela Scalas (D)

Department of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Torino, Italy.

Luigi Bertolotti (L)

Department of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Torino, Italy.

Alessio Bortolami (A)

Department of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Universita' 10, 35020 Legnaro, PD, Italy.

Matteo Pagliari (M)

Department of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Universita' 10, 35020 Legnaro, PD, Italy.

Giulia Pezzoni (G)

National Reference Centre for Vesicular Diseases, Dpt. Biotechnology, OIE/FAO reference laboratories for FMD and for SVD, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Via Bianchi 9, 25124, Brescia, Italy.

Ana Moreno (A)

Virology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, 25124 Brescia, Italy.

Davide Lelli (D)

Virology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, 25124 Brescia, Italy.

Maria Silvia Gennero (MS)

The Veterinary Medical Research Institute for Piemonte, Liguria and Valle d'Aosta, via Bologna 148, 10154 Turin, Italy.

Alessandro Dondo (A)

The Veterinary Medical Research Institute for Piemonte, Liguria and Valle d'Aosta, via Bologna 148, 10154 Turin, Italy.

Emiliana Brocchi (E)

National Reference Centre for Vesicular Diseases, Dpt. Biotechnology, OIE/FAO reference laboratories for FMD and for SVD, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Via Bianchi 9, 25124, Brescia, Italy.

Sergio Rosati (S)

Department of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH